Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease Progression

被引:40
作者
Marcon, Julian [1 ]
DiNatale, Renzo G. [1 ]
Sanchez, Alejandro [1 ]
Kotecha, Ritesh R. [2 ]
Gupta, Sounak [3 ]
Kuo, Fengshen [4 ]
Makarov, Vladimir [4 ]
Sandhu, Amar [5 ]
Mano, Roy [1 ]
Silagy, Andrew W. [1 ]
Blum, Kyle A. [1 ]
Nassau, Daniel E. [1 ]
Benfante, Nicole E. [1 ]
Ortiz, Michael, V [6 ]
Carlo, Maria, I [2 ]
Chan, Timothy A. [4 ,7 ]
Motzer, Robert J. [2 ]
Voss, Martin H. [2 ]
Coleman, Jonathan [1 ]
Russo, Paul [1 ]
Reuter, Victor [3 ]
Hakimi, A. Ari [1 ]
Reznik, Ed [5 ,8 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA
[4] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA
[5] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Computat Oncol Serv, New York, NY 10065 USA
[6] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10065 USA
[7] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA
[8] Mem Sloan Kettering Canc Ctr, Ctr Mol Oncol, New York, NY 10065 USA
关键词
CANCER; DISCOVERY; EXPRESSION; EMPHASIS; MUTATION; FEATURES; FUSIONS; IMPACT; KIDNEY; ASSAY;
D O I
10.1158/1078-0432.CCR-19-3283
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Translocation renal cell carcinoma (tRCC) is a rare, aggressive renal cell carcinoma (RCC) subtype. There is currently limited understanding on the role of molecular alterations in the pathogenesis and progression of these tumors. We investigated the association between somatic alterations and clinical outcomes in two independent cohorts profiled using DNA sequencing. Experimental Design: Twenty-two tRCCs underwent targeted sequencing [Memorial Sloan Kettering Cancer Center (MSK)-IMPACT]; a subset was profiled using exome-sequencing and combined with exome data from The Cancer Genome Atlas (TCGA) for analysis. The prognostic value of specific somatic aberrations, tumor mutation burden (TMB), and fraction of copy-number- altered genome (FCNAg) was explored. In TCGA cases, neoantigen prediction and immune cell deconvolution were performed using RNA-sequencing and exome data. Overall survival estimates were computed using the Kaplan-Meier method; time-on-treatment was calculated for 14 MSK-IMPACT patients who underwent systemic therapy. Associations between molecular features and outcomes were evaluated using nonparametric testing. Results: Copy-number aberrant tRCCs were associated with poor overall survival (P = 0.03). Pediatric patients had tumors with lower FCNAg (P = 0.01). In one adult case with two chronologically distinct tumor samples sequenced, we confirmed that copy-number events occurred early during evolution. TERT promoter mutations were found exclusively in high-stage tumors. We found that tRCCs displayed distinct angiogenesis and PDL1 gene expression profiles compared with other RCC subtypes. Conclusions: Tumors molecularly defined by increased copynumber variations were associated with aggressive disease in tRCC. A higher burden of genomic events in adults compared with pediatric cases likely reflects a more aggressive clinical course. The unique immunophenotypic characteristics of tRCC merit further exploration.
引用
收藏
页码:3629 / 3640
页数:12
相关论文
共 50 条
[1]   A map of human genome variation from population-scale sequencing [J].
Altshuler, David ;
Durbin, Richard M. ;
Abecasis, Goncalo R. ;
Bentley, David R. ;
Chakravarti, Aravinda ;
Clark, Andrew G. ;
Collins, Francis S. ;
De la Vega, Francisco M. ;
Donnelly, Peter ;
Egholm, Michael ;
Flicek, Paul ;
Gabriel, Stacey B. ;
Gibbs, Richard A. ;
Knoppers, Bartha M. ;
Lander, Eric S. ;
Lehrach, Hans ;
Mardis, Elaine R. ;
McVean, Gil A. ;
Nickerson, DebbieA. ;
Peltonen, Leena ;
Schafer, Alan J. ;
Sherry, Stephen T. ;
Wang, Jun ;
Wilson, Richard K. ;
Gibbs, Richard A. ;
Deiros, David ;
Metzker, Mike ;
Muzny, Donna ;
Reid, Jeff ;
Wheeler, David ;
Wang, Jun ;
Li, Jingxiang ;
Jian, Min ;
Li, Guoqing ;
Li, Ruiqiang ;
Liang, Huiqing ;
Tian, Geng ;
Wang, Bo ;
Wang, Jian ;
Wang, Wei ;
Yang, Huanming ;
Zhang, Xiuqing ;
Zheng, Huisong ;
Lander, Eric S. ;
Altshuler, David L. ;
Ambrogio, Lauren ;
Bloom, Toby ;
Cibulskis, Kristian ;
Fennell, Tim J. ;
Gabriel, Stacey B. .
NATURE, 2010, 467 (7319) :1061-1073
[2]   Gapped sequence alignment using artificial neural networks: application to the MHC class I system [J].
Andreatta, Massimo ;
Nielsen, Morten .
BIOINFORMATICS, 2016, 32 (04) :511-517
[3]   Translocation carcinomas of the kidney after chemotherapy in childhood [J].
Argani, P ;
Laé, M ;
Ballard, ET ;
Amin, M ;
Manivel, C ;
Hutchinson, B ;
Reuter, VE ;
Ladanyi, M .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (10) :1529-1534
[4]   Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 [J].
Barbie, David A. ;
Tamayo, Pablo ;
Boehm, Jesse S. ;
Kim, So Young ;
Moody, Susan E. ;
Dunn, Ian F. ;
Schinzel, Anna C. ;
Sandy, Peter ;
Meylan, Etienne ;
Scholl, Claudia ;
Froehling, Stefan ;
Chan, Edmond M. ;
Sos, Martin L. ;
Michel, Kathrin ;
Mermel, Craig ;
Silver, Serena J. ;
Weir, Barbara A. ;
Reiling, Jan H. ;
Sheng, Qing ;
Gupta, Piyush B. ;
Wadlow, Raymond C. ;
Le, Hanh ;
Hoersch, Sebastian ;
Wittner, Ben S. ;
Ramaswamy, Sridhar ;
Livingston, David M. ;
Sabatini, David M. ;
Meyerson, Matthew ;
Thomas, Roman K. ;
Lander, Eric S. ;
Mesirov, Jill P. ;
Root, David E. ;
Gilliland, D. Gary ;
Jacks, Tyler ;
Hahn, William C. .
NATURE, 2009, 462 (7269) :108-U122
[5]   Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer [J].
Bindea, Gabriela ;
Mlecnik, Bernhard ;
Tosolini, Marie ;
Kirilovsky, Amos ;
Waldner, Maximilian ;
Obenauf, Anna C. ;
Angell, Helen ;
Fredriksen, Tessa ;
Lafontaine, Lucie ;
Berger, Anne ;
Bruneval, Patrick ;
Fridman, Wolf Herman ;
Becker, Christoph ;
Pages, Franck ;
Speicher, Michael R. ;
Trajanoski, Zlatko ;
Galon, Jerome .
IMMUNITY, 2013, 39 (04) :782-795
[6]   Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders [J].
Boileve, A. ;
Carlo, M. I. ;
Barthelemy, P. ;
Oudard, S. ;
Borchiellini, D. ;
Voss, M. H. ;
George, S. ;
Chevreau, C. ;
Landman-Parker, J. ;
Tabone, M-D ;
Chism, D. D. ;
Amin, A. ;
Bilen, M. A. ;
Bosse, D. ;
Coulomb-L'hermine, A. ;
Su, Xiaoping ;
Choueiri, T. K. ;
Tannir, Nizar M. ;
Malouf, Gabriel G. .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
[7]   Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma [J].
Brunelli, Matteo ;
Eccher, Albino ;
Gobbo, Stefano ;
Ficarra, Vincenzo ;
Novara, Giacomo ;
Cossu-Rocca, Paolo ;
Bonetti, Franco ;
Menestrina, Fabio ;
Cheng, Liang ;
Eble, John N. ;
Martignoni, Guido .
MODERN PATHOLOGY, 2008, 21 (01) :1-6
[8]   The Classification of Pediatric and Young Adult Renal Cell Carcinomas Registered on the Children's Oncology Group (COG) Protocol AREN03B2 After Focused Genetic Testing [J].
Cajaiba, Mariana M. ;
Dyer, Lisa M. ;
Geller, James I. ;
Jennings, Lawrence J. ;
George, David ;
Kirschmann, Dawn ;
Rohan, Stephen M. ;
Cost, Nicholas G. ;
Khanna, Geetika ;
Mullen, Elizabeth A. ;
Dome, Jeffrey S. ;
Fernandez, Conrad V. ;
Perlman, Elizabeth J. .
CANCER, 2018, 124 (16) :3381-3389
[9]   Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma [J].
Casuscelli, Jozefina ;
Becerra, Maria F. ;
Manley, Brandon J. ;
Zabor, Emily C. ;
Reznik, Ed ;
Redzematovic, Almedina ;
Arcila, Maria E. ;
Tennenbaum, Daniel M. ;
Ghanaat, Mazyar ;
Kashan, Mahyar ;
Stief, Christian G. ;
Carlo, Maria ;
Voss, Martin H. ;
Feldman, Darren R. ;
Motzer, Robert J. ;
Chen, Yingbei ;
Reuter, Victor E. ;
Coleman, Jonathan A. ;
Russo, Paul ;
Hsieh, James J. ;
Hakimi, Abraham Ari .
EUROPEAN UROLOGY FOCUS, 2019, 5 (04) :642-649
[10]  
Chakravarty D, 2017, JCO PRECIS ONCOL, V1